CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Vanda Pharmaceuticals' Skin Disease Drug Gets EU Orphan Drug Designation

RegulatoryPositive
AI Analysis

Summary

Vanda Pharmaceuticals received EU Orphan Drug Designation for a skin disease treatment, providing regulatory incentives and market protection in Europe.

Outcome Details

EU Orphan Drug Designation granted

Importance:5/10
Sentiment:
0.60
orphan_drugEU_regulationdermatology
Related Companies

Read the original article

Published by yahoo_finance on August 24, 2026 11:41 AM

Read Original